Sarah Ngamau

Pictured: The key players in Rocket Health’s dramatic transformation — Dr. Davis Musinguzi, the pioneering founder who led the company through its early growth, before running rogue; Pierre Fauvet of Creadev, the lead Series A investor who championed governance reforms and engineered the merger to protect investor value; and Neil O’Leary, Chairman of MYDAWA, who executed the acquisition that absorbed Rocket Health into a larger regional healthcare platform. Together, they represent the vision, capital, and consolidation that has defined one of East Africa’s most consequential startup power shifts.

THE INSIDE STORY: How Dr. Davis Musinguzi & Partners Built and Lost Telemedicine Pioneer, Rocket Health  Africa

When a group of young medical and finance professionals in Uganda came together in 2012, they had a bold vision: to transform healthcare access through technology. Dr. Davis Musinguzi (CEO), alongside Dr.
Rocket Health Founders (Left-Right) Dr. John Mark Bwanika - Co-founder and Chief Operations Officer; Dr. Davis Musinguzi, Managing Director; Fiona Nuwamanya - Chief Finance Officer; Hope Fortunate Achiro - Co-founder and Chief Pharmacy Officer; Dr. William Lubega - Co-founder and Chief Medical Officer. The company, in March 2022, closed a USD5 million Series A funding round led by Creadev, an evergreen investment fund backed by the Mulliez Family of French entrepreneurs.PHOTO/Courtesy

Rocket Health gets a USD5m shot in the arm from Creadev Africa in Series A round funding to fuel East African expansion

Rocket Health, a telemedicine and last-mile healthcare provider headquartered in Uganda, has announced this morning, that it has closed a USD5 million Series A funding round led by Creadev, an evergreen investment

 

Follow

error: Content is protected !!